GENB

Conviction 100HealthcareScan · Thu, Jun 25, 2026

GENB$16.44+1.29%

ResistanceSupportVol 14

Vol MA14 1.35M

Mar 26Apr 14May 1May 19Jun 8Jun 25

WSB mentions · 24h changelatest +200.00%· 3 mentions

Mar 26Apr 14May 1May 19Jun 8Jun 25

Generate Biomedicines, Inc.Biotechnologywww.generatebiomedicines.com ↗

Price16.44

Change+1.29%

Gap+0.18%

Rel volume7.28×

Avg volume1.25M

Avg $ vol18.17M

SMA 2013.77

SMA 5013.66

SMA 200—

Price vs 50+20.38%

Price vs 200—

MA stack—

50/200 cross—

Supertrendup · 13.15

RSI (14)64

MACD hist0.37

MACD crossbull · 5d

Stoch %K / %D82 / 84

ADX (14)22

+DI / −DI36 / 12

RSI divergence—

MACD divergence—

ATR %+7.17%

ADR %7.83%

52w high16.44

52w low11.21

From 52w high+0.00%

Above 52w low+46.65%

New 52w highYes

SqueezeOff

Bollinger width37.13%

%B1.02

Donchian pos83.06%

Donchian high17.37

Donchian low11.88

AVWAP (52w high)16.62

vs AVWAP high-1.10%

AVWAP (52w low)13.74

vs AVWAP low+19.68%

OBV trendUp

Chaikin MF (20)-0.01

Today vs 20d7.28×

Avg vol (14d)1.35M

Avg vol (20d)1.25M

Avg $ vol (20d)18.17M

Market cap2.11B

RS 3m (vs SPY)+22.66%

RS 6m (vs SPY)—

RS line new highYes

Trend template—

Technical rank92.4

1 week+18.53%

1 month+23.24%

3 months+38.97%

6 months—

1 year—

YTD+29.96%

P/E—

P/B4.09

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current9.17

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target25.40

Target upside54.50%

Analyst ratingBuy

Institutional71.76%

Ent. value1.95B

Revenue7.22M

Net income-61.45M

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out128.19M

Employees—

ListedFri, Feb 27, 2026

Free float97.95M

Float %76.4%

Short interest4.09M

Days to cover4.8d

Short volume64.8%

Squeeze score64 / 100

Next earningsThu, Aug 6, 2026 (42d)

EPS forecast−$0.48 · 3 est

Last EPS vs est−$1.07 vs −$0.48

Last surprise-122.9% miss

Setup gradeA+

Conviction100 / 100

Pattern quality—

Tech rank92.4 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance16.32

Support12.03

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in GENB

All disclosures →

No recent disclosed trades by Congress in GENB. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in GENB

No recent insider (Form 4) filings in GENB. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in GENB

EDGAR →

No recent SEC filings on file for GENB.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.